Company: BIVIW
Filing Date: 2025-06-27
Form Type: 8-K
Source: 0001520138-25-000190
Chunk: 1

Company: BIOVIE INC.
Filing Date: 2025-06-27
Form: 8-K
Item: Item 3.03
Chunk 1
---
 to take any action.

Commencing on July 7, 2025, trading of the Company’s
Common Stock will continue on The Nasdaq Capital Market on a Reverse Stock Split-adjusted basis. The new CUSIP number for the Company’s
Common Stock following the Reverse Stock Split will be 09074F504.

SIGNATURES

Pursuant to the requirements of the Securities Exchange
Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  BioVie INC.                                                         
  By:              /s/ Joanne Wendy Kim                               
                   Name:                     Joanne Wendy Kim         
                   Title:                    Chief Financial Officer